Interleukine-1β and interleukine-6 levels in striatum and other brain structures after MPTP treatment: Influence of behavioral lateralization

Journal of Neuroimmunology

Volumn 158, Issue 1-2, 2005, Pages 14-25

  Shen, Yan Qin ^a,b   Hebert, Guillaum ^b   Lin, Ling Yun ^c   Luo, Yan Ling ^a   Moze, Elizabeth ^b   Li, Kang Sheng ^a   Neveu, Pierre J ^b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

^c SHANDONG MENTAL HEALTH CENTER   (China)

Author keywords

Behavioral lateralization; Brain; Dopamine; Interleukin 1 ; Interleukin 6; N methyl 4 phenyl 1,2,3,6 tetrahydropyridine

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; BRAIN PROTEIN; CYTOKINE; DOPAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; DOPAMINE RECEPTOR STIMULATING AGENT; INTERLEUKIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMISPHERIC DOMINANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; BRAIN LEVEL; C57BL MOUSE; COMPARATIVE STUDY; DRUG EFFECT; FEEDING BEHAVIOR; INTOXICATION; METABOLISM; METHODOLOGY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEEDING BEHAVIOR; FUNCTIONAL LATERALITY; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING;

EID: 10344238575     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.06.011     Document Type: Article

References (60)

1. S.F. Ali, S.N. David, and G.D. Newport Age-related susceptibility to MPTP-induced neurotoxicity in mice Neurotoxicology 14 1993 29 34
2. H.R. Anforth, R.M. Bluthe, A. Bristow, S. Hopkins, M.J. Lenczowski, G. Luheshi, J. Lundkvist, B. Michaud, Y. Mistry, A.M. Van Dam, C. Zhen, R. Dantzer, S. Poole, N.J. Rothwell, F.J. Tilders, and E.E. Wollman Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta Eur. Cytokine Netw. 9 1998 279 288
3. Y. Araki, A. Andoh, Y. Fujiyama, K. Hata, J. Makino, T. Okuno, F. Nakanura, and T. Bamba Application of 2-aminopyridine fluorescence labeling in the analysis of in vivo and in vitro metabolism of dextran sulfate sodium by size-exclusion high-performance liquid chromatography J. Chromatogr., B, Biomed. Sci. Appl. 753 2001 209 215
4. A. Avital, I. Goshen, A. Kamsler, M. Segal, K. Iverfeldt, G. Richter-Levin, and R. Yirmiya Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity Hippocampus 13 2003 826 834
5. J. Bas, M. Calopa, M. Mestre, D.G. Mollevi, B. Cutillas, S. Ambrosio, and E. Buendia Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism J. Neuroimmunol. 113 2001 146 152
6. F.P. Bellinger, S. Madamba, and G.R. Siggins Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus Brain Res. 628 1993 227 234
7. M. Bianchi, P. Sacerdote, and A.E. Panerai Cytokines and cognitive function in mice Biol. Signals Recept. 7 1998 45 54
8. M. Bianchi, P. Sacerdote, P. Ricciardi-Castagnoli, P. Mantegazza, and A.E. Panerai Central effects of tumor necrosis factor alpha and interleukin-1 alpha on nociceptive thresholds and spontaneous locomotor activity Neurosci. Lett. 148 1992 76 80
9. K. Bieganowska, A. Czlonkowska, A. Bidzinski, H. Mierzewska, and J. Korlak Immunological changes in the MPTP-induced Parkinson's disease mouse model J. Neuroimmunol. 42 1993 33 37
10. K. Bieganowska, A. Czonkowska, and J. Korlak Pargyline pretreatment prevents immunological changes induced by MPTP in mice Immunopharmacology 35 1996 149 154
11. R.M. Bluthe, S. Laye, B. Michaud, C. Combe, R. Dantzer, and P. Parnet Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice Eur. J. Neurosci. 12 2000 4447 4456
12. L.M. Bolin, I. Strycharska-Orczyk, R. Murray, J.W. Langston, and D. Di Monte Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice J. Neurochem. 83 2002 167 175
13. A.M. Bratt, S.P. Kelley, J.P. Knowles, J. Barrett, K. Davis, M. Davis, and G. Mittleman Long term modulation of the HPA axis by the hippocampus. Behavioral, biochemical and immunological endpoints in rats exposed to chronic mild stress Psychoneuroendocrinology 26 2001 121 145
14. W.J. Brooks, M.F. Jarvis, and G.C. Wagner Astrocytes as a primary locus for the conversion MPTP into MPP+ J. Neural Transm. 76 1989 1 12
15. H. Cardenas, and L.M. Bolin Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice Brain Res. 985 2003 89 97
16. P. Casolini, A. Catalani, A.R. Zuena, and L. Angelucci Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat J. Neurosci. Res. 68 2002 337 343
17. J.A. Cochiolo, R. Ehsanian, and D.K. Bruck Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: evidence of compensatory plasticity in nigrostriatal neurons J. Neurosci. Res. 59 2000 126 135
18. R.L. Collins On the inheritance of direction and degree of asymmetry S.D. Glick Cerebral Lateralization in Non human Species 1985 Academic Press New York 41 71
19. C. Da Cunha, M.E. Angelucci, N.S. Canteras, S. Wonnacott, and R.N. Takahashi The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities Cell. Mol. Neurobiol. 22 2002 227 237
20. R. Dantzer Cytokine-induced sickness behavior: mechanisms and implications Ann. N.Y. Acad. Sci. 933 2001 222 234
21. D.A. Di Monte, J.E. Royland, I. Irwin, and J.W. Langston Astrocytes as the site for bioactivation of neurotoxins Neurotoxicology 17 1996 697 703
22. D.E. Dluzen, and J.D. Kreutzberg 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) disrupts social memory/recognition processes in the male mouse Brain Res. 609 1993 98 102
23. J. Dong, O. Mrabet, E. Moze, K. Li, and P.J. Neveu Lateralization and catecholaminergic neuroimmunomodulation: prazosin, an alpha1/alpha2-adrenergic receptor antagonist, suppresses interleukin-1 and increases interleukin-10 production induced by lipopolysaccharides Neuroimmunomodulation 10 2002 163 168
24. J. Fernandez-Ruiz, D.J. Doudet, and T.G. Aigner Long-term cognitive impairment in MPTP-treated rhesus monkeys Neuroreport 7 1995 102 104
25. C.C. Ferri, and A.V. Ferguson Interleukin-1 beta depolarizes paraventricular nucleus parvocellular neurones J. Neuroendocrinol. 15 2003 126 133
26. Q.L. Fu, Y.Q. Shen, M.X. Gao, J. Dong, P.J. Neveu, and K.S. Li Brain interleukin asymmetries and paw preference in mice Neuroscience 116 2003 639 647
27. M.X. Gao, K. Li, J. Dong, S. Liege, B. Jiang, and P.J. Neveu Strain-dependent association between lateralization and lipopolysaccharide- induced IL-1beta and IL-6 production in mice Neuroimmunomodulation 8 2000 78 82
28. M. Gerlach, and P. Riederer Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man J. Neural Transm. 103 1996 987 1041
29. K. Hamre, R. Tharp, K. Poon, X. Xiong, and R.J. Smeyne Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus Brain Res. 828 1999 91 103
30. G. Hebert, J. Arsaut, R. Dantzer, and J. Demotes-Mainard Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine, a dopaminergic neurotoxin Neurosci. Lett. 349 2003 191 195
31. C.J. Heyser, E. Masliah, A. Samimi, I.L. Campbell, and L.H. Gold Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain Proc. Natl. Acad. Sci. U. S. A. 94 1997 1500 1505
32. A. Ho, and M. Blum Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease J. Neurosci. 18 1998 5614 5629
33. K. Kaku, T. Shikimi, Y. Kamisaki, K. Shinozuka, H. Ishino, H. Okunishi, and S. Takaori Elevation of striatal interleukin-6 and serum corticosterone contents in MPTP-treated mice Clin. Exp. Pharmacol. Physiol. 26 1999 680 683
34. H. Katsuki, S. Nakai, Y. Hirai, K. Akaji, Y. Kiso, and M. Satoh Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices Eur. J. Pharmacol. 181 1990 323 326
35. M. Kohutnicka, E. Lewandowska, I. Kurkowska-Jastrzebska, A. Czlonkowski, and A. Czlonkowska Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Immunopharmacology 39 1998 167 180
36. I. Kurkowska-Jastrzebska, A. Wronska, M. Kohutnicka, A. Czlonkowski, and A. Czlonkowska MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease Acta Neurobiol. Exp. (Warsz) 59 1999 1 8
37. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
38. N. Matsumoto, T. Hanakawa, S. Maki, A.M. Graybiel, and M. Kimura Role of [corrected] nigrostriatal dopamine system in learning to perform sequential motor tasks in a predictive manner J. Neurophysiol. 82 1999 978 998
39. E. Miyoshi, S. Wietzikoski, M. Camplessei, R. Silveira, R.N. Takahashi, and C. Da Cunha Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions Brain Res. Bull. 58 2002 41 47
40. M. Mogi, A. Togari, M. Ogawa, K. Ikeguchi, N. Shizuma, D. Fan, I. Nakano, and T. Nagatsu Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1beta and nerve growth factor in the striatum Neurosci. Lett. 250 1998 25 28
41. T. Muller, D. Blum-Degen, H. Przuntek, and W. Kuhn Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease Acta Neurol. Scand. 98 1998 142 144
42. P.J. Neveu Cerebral lateralization and the immune system Int. Rev. Neurobiol. 52 2002 303 323
43. P.J. Neveu, and E. Merlot Cytokine stress responses depend on lateralization in mice Stress 6 2003 5 9
44. P.J. Neveu, P. Barneoud, S. Vitiello, C. Betancur, and M. Le Moal Brain modulation of the immune system: association between lymphocyte responsiveness and paw preference in mice Brain Res. 457 1988 392 394
45. P.J. Neveu, R.M. Bluthe, S. Liege, S. Moya, B. Michaud, and R. Dantzer Interleukin-1-induced sickness behavior depends on behavioral lateralization in mice Physiol. Behav. 63 1998 587 590
46. G. Pacheco-Lopez, M.B. Niemi, W. Kou, A. Bildhauser, C.M. Gross, M.U. Goebel, A. del Rey, H.O. Besedovsky, and M. Schedlowski Central catecholamine depletion inhibits peripheral lymphocyte responsiveness in spleen and blood J. Neurochem. 86 2003 1024 1031
47. C.L. Parish, D.I. Finkelstein, W. Tripanichkul, A.R. Satoskar, J. Drago, and M.K. Horne The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice J. Neurosci. 22 2002 8034 8041
48. J.C. Perry, C. Da Cunha, J. Anselmo-Franci, R. Andreatini, E. Miyoshi, S. Tufik, and M.A. Vital Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats Eur. J. Pharmacol. 484 2004 225 233
49. E. Petroske, G.E. Meredith, S. Callen, S. Totterdell, and Y.S. Lau Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment Neuroscience 106 2001 589 601
50. C. Pifl, G. Schingnitz, and O. Hornykiewicz Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey Neuroscience 44 1991 591 605
51. E. Rousselet, J. Callebert, K. Parain, C. Joubert, S. Hunot, A. Hartmann, C. Jacque, F. Perez-Diaz, C. Cohen-Salmon, J.M. Launay, and E.C. Hirsch Role of TNF-alpha receptors in mice intoxicated with the parkinsonian toxin MPTP Exp. Neurol. 177 2002 183 192
52. J. Saura, M. Pares, J. Bove, S. Pezzi, J. Alberch, C. Marin, E. Tolosa, and M.J. Marti Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity J. Neurochem. 85 2003 651 661
53. H. Schneider, F. Pitossi, D. Balschun, A. Wagner, A. del Rey, and H.O. Besedovsky A neuromodulatory role of interleukin-1beta in the hippocampus Proc. Natl. Acad. Sci. U. S. A. 95 1998 7778 7783
54. P.A. Serra, L. Sciola, M.R. Delogu, A. Spano, G. Monaco, E. Miele, G. Rocchitta, M. Miele, R. Migheli, and M.S. Desole The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes J. Biol. Chem. 277 2002 34451 34461
55. H. Tanila, M. Bjorklund, and P. Riekkinen Jr Cognitive changes in mice following moderate MPTP exposure Brain Res. Bull. 45 1998 577 582
56. N.A. Tatton, and S.J. Kish In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining Neuroscience 77 1997 1037 1048
57. M. Vila, V. Jackson-Lewis, S. Vukosavic, R. Djaldetti, G. Liberatore, D. Offen, S.J. Korsmeyer, and S. Przedborski Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 98 2001 2837 2842
58. L. Vitkovic, J.P. Konsman, J. Bockaert, R. Dantzer, V. Homburger, and C. Jacque Cytokine signals propagate through the brain Mol. Psychiatry 5 2000 604 615
59. J. Wang, K.S. Bankiewicz, R.J. Plunkett, and E.H. Oldfield Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain J. Neurosurg. 80 1994 484 490
60. D.C. Wu, V. Jackson-Lewis, M. Vila, K. Tieu, P. Teismann, C. Vadseth, D.K. Choi, H. Ischiropoulos, and S. Przedborski Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson disease J. Neurosci. 22 2002 1763 1771